Caitlin has a decade’s worth of diverse experience in clinical research. She found her passion while working with the lung cancer group at UCLA, most notably as lead Data Manager for the Phase I trial of Keytruda. She moved on to coordinate trials for AML and other hematologic malignancies at OHSU’s Knight Cancer Institute and further solidified her clinical foundation by monitoring oncology trials in partnership with Eli Lilly. Most recently, Caitlin built investigator relationships in a Site Engagement role for UCB’s rare disease program and guided activities as Clinical Operations Manager for the growing biotech, Xencor.
Caitlin graduated from Drexel University with a degree in Biological Sciences.